1. Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model
   Lunjie Lu et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries
   Sung-Chou Li et al, 2016, IJMS CrossRef
3. TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy
   Ammad Farooqi et al, 2017, IJMS CrossRef
4. MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7
   Li-Ying Song et al, 2017, BioMed Research International CrossRef
5. Anti-hepatic fibrosis effects of a novel turtle shell decoction by inhibiting hepatic stellate cell proliferation and blocking TGF-β1/Smad signaling pathway in rats
   Ganping Bai et al, 2016 CrossRef
6. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI
   Mingyue Tan et al, 2017, Mol Carcinog CrossRef
7. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis
   Xiaohua Yan et al, 2017 CrossRef
8. Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
   Joanne E. Murphy-Ullrich et al, 2017, Matrix Biology CrossRef
9. Hepatocellular Carcinoma Metastasis and Circulating Tumor Cells
   Kien Pham et al, 2018 CrossRef
10. Integrated Computational Model of Intracellular Signaling and microRNA Regulation Predicts the Network Balances and Timing Constraints Critical to the Hepatic Stellate Cell Activation Process
    Lakshmi Kuttippurathu et al, 2014, Processes CrossRef
11. The role of oxymatrine in regulating TGF-β1 in rats with hepatic fibrosis
    Jing Wu et al, 2018, Acta Cir. Bras. CrossRef
12. Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression
    Geng Qin et al, 2018, Journal of Digestive Diseases CrossRef
13. Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats
    Masatsugu Ohara et al, 2018, Front. Pharmacol. CrossRef
14. Artificial microRNA mediated Tgfbr2 and Pdgfrb co-silencing ameliorates CCl4-induced hepatic fibrosis in mice
    Yan Jiang et al, 2018, Human Gene Therapy CrossRef
15. Effects of FGF21-secreting adipose-derived stem cells in thioacetamide-induced hepatic fibrosis
    Hwansu Kang et al, 2018, J Cell Mol Med CrossRef
16. Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity
    Yu Xia et al, 2018, Biomedicine & Pharmacotherapy CrossRef
17. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
    Chao Wu et al, 2019, J Ethnopharmacol CrossRef
18. Resveratrol Inhibits the TGF-β1-Induced Proliferation of Cardiac Fibroblasts and Collagen Secretion by Downregulating miR-17 in Rat
    Yao Zhang et al, 2018, BioMed Research International CrossRef
19. Lonicera japonica Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice: Molecular Mechanisms of Action
    Hui Miao et al, 2019, Am. J. Chin. Med. CrossRef
20. Insulin-like growth factor binding protein-4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C-X-C chemokine receptor 4
    YunYun Su et al, 2019, FASEB BioAdvances CrossRef
21. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice
    Ya-Ling Yang et al, 2019, IJMS CrossRef
22. Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia
    Tatiana Iordanskaia et al, 2015, Mol Med CrossRef
23. Buckwheat Treatment Ameliorates Transforming Growth Factor Beta-1, its Receptor Gene Expression and Biochemical Parameters in Experimental Steatohepatitis
    Sahar Y. Al-Okbi et al, 2019, International J. of Botany CrossRef
24. Precancerous niche (PCN), a product of fibrosis with remodeling by incessant chronic inflammation
    Björn L.D.M. Brücher et al, 2019, 4open CrossRef
25. Tumor Stroma, Desmoplasia, and Stromagenesis
    Arthur Zimmermann, 2016 CrossRef
26. Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-ß1)
    Felipe Cabezas et al, 2019, PLoS ONE CrossRef
27. Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway
    Li-Ying Song et al, 2019, BMC Complement Altern Med CrossRef
28. BMP signalling: agony and antagony in the family
    Derek P. Brazil et al, 2015, Trends in Cell Biology CrossRef
29. MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells
    A. Boye et al, 2015, Tumor Biol. CrossRef
30. Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice
    April K. Marrone et al, 2016, Mol. Carcinog. CrossRef
31. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism
    Alex Boye et al, 2015, Journal of Ethnopharmacology CrossRef
32. MiR-27a-3p downregulation contributes to the development of occlusive bronchiolitis
    Ming Dong et al, 2019, Cell Stress and Chaperones CrossRef
33. Homocysteine Induces Collagen I Expression by Downregulating Histone Methyltransferase G9a
    Wenjing Lei et al, 2015, PLoS ONE CrossRef
34. Fasciola hepatica Infection in Cattle: Analyzing Responses of Peripheral Blood Mononuclear Cells (PBMC) Using a Transcriptomics Approach
    Andres Garcia-Campos et al, 2019, Front. Immunol. CrossRef
35. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways
    Pengfei Xu et al, 2016, Toxicology and Applied Pharmacology CrossRef
36. Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study
    Yani Liu et al, 2017, Eur J Drug Metab Pharmacokinet CrossRef
37. TGF-β signalling and liver disease.
    Isabel Fabregat et al, 2016, FEBS J CrossRef
38. The rationale for targeting TGF-β in chronic liver diseases
    Gianluigi Giannelli et al, 2016, Eur J Clin Invest CrossRef
39. Activation of corticotropin releasing factor receptors up regulates collagen production by hepatic stellate cells via promoting p300 expression
    Changzhen Wang et al, 2016 CrossRef
40. Screening for and validation of a hepatic fibrosis-related pathway induced by insulin-like growth factor-binding protein-related protein 1.
    XiaoHong Guo et al, 2016, Eur J Gastroenterol Hepatol CrossRef
41. Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma
    Yutaka Yasui et al, 2016, PLoS ONE CrossRef
42. SP1 and UTE1 Decoy ODNs inhibit activation and proliferation of hepatic stellate cells by targeting tissue inhibitors of metalloproteinase 1
    Dong Jia et al, 2016, Cell Biosci CrossRef
43. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells.
    Yan Li et al, 0 CrossRef
44. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation
    Yuping Zhou et al, 2016, Journal of Ethnopharmacology CrossRef
45. Transcriptomic Study on Ovine Immune Responses to Fasciola hepatica Infection
    Yan Fu et al, 2016, PLoS Negl Trop Dis CrossRef
46. Tumor Stroma, Desmoplasia, and Stromagenesis
    Arthur Zimmermann, 2017 CrossRef
47. Drug-induced chromatin accessibility changes associate with sensitivity to liver tumor promotion
    Antonio Vitobello et al, 2019, Life Sci. Alliance CrossRef
48. Obeticholic acid prevents carbon tetrachloride-induced liver fibrosis through interaction between farnesoid X receptor and Smad3
    Yuan-Yuan Fan et al, 2019, International Immunopharmacology CrossRef
49. Lysyl oxidases: linking structures and immunity in the tumor microenvironment
    Paolo Tenti et al, 2019, Cancer Immunol Immunother CrossRef
50. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro
    Chao Wu et al, 2019, Life Sciences CrossRef
51. Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways
    Maha G. Elfeky et al, 2019, Life Sciences CrossRef
52. Platyconic Acid A, Platycodi Radix-Derived Saponin, Suppresses TGF-β1-Induced Activation of Hepatic Stellate Cells via Blocking SMAD and Activating the PPARγ Signaling Pathway
    Jae Ho Choi et al, 2019, Cells CrossRef
53. Autologous fibroblasts induce fibrosis of the nucleus pulposus to maintain the stability of degenerative intervertebral discs
    Chen Chen et al, 2020, Bone Res CrossRef
54. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond
    Hung-Yu Lin et al, 2020, Cells CrossRef
55. miR-4286/TGF-β1/Smad3-Negative Feedback Loop Ameliorated Vascular Endothelial Cell Damage by Attenuating Apoptosis and Inflammatory Response
    Zhiyu He et al, 2020, Journal of Cardiovascular Pharmacology CrossRef
56. Increased risk of malignancy in patients with an aortic aneurysm: a nationwide population-based retrospective study
    Jen-Chun Wang et al, 2018, Oncotarget CrossRef
57. CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
    Runzhou Zhuang et al, 2017, Oncotarget CrossRef
58. Smad3 gene C‐terminal phosphorylation site mutation aggravates CCl 4 ‐induced inflammation in mice
    Hanyan Ding et al, 2020, J Cell Mol Med CrossRef
59. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: A promising therapeutic strategy for hepatic fibrosis — A review
    Yongfang Gong et al, 2020, Life Sciences CrossRef
60. Identification and integrative analysis of microRNAs and mRNAs involved in proliferation and invasion of pressure‑treated human liver cancer cell lines
    Si Shen et al, 2019, Mol Med Report CrossRef
61. miR‑127 aggravates myocardial failure by promoting the TGF‑β1/Smad3 signaling
    Hainian Xu et al, 2018, Mol Med Report CrossRef
62. Class�C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cells
    Chun Rao et al, 2019, Mol Med Report CrossRef
63. Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells
    Kang Ho Kim et al, 2016 CrossRef
64. Depletion of serotonin relieves concanavalin A-induced liver fibrosis in mice by inhibiting inflammation, oxidative stress, and TGF-β1/Smads signaling pathway
    Qing Pang et al, 2021, Toxicology Letters CrossRef
65. MiR-15b and miR-16 suppress TGF-β1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells
    Li Ma et al, 2021, Life Sciences CrossRef
66. Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor
    Dong-Jing Yang et al, 2021, Sci Rep CrossRef
67. ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment
    Nathalie Théret et al, 2021, Cancers CrossRef
68. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
    Chong Zhang et al, 2021, J Ethnopharmacol CrossRef
69. mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease
    Marwa Matboli et al, 2021, IJMS CrossRef
70. Fibroblast Growth Factor 21 Reduces Cholesterol-Induced Hepatic Fibrogenesis by Inhibiting TGF-β/Smad3C Signaling Pathway in LX2 Cells
    Reza Afarin et al, 2021, Hepat Mon CrossRef
71. Effect of Quercetin on the Expression of NOXs and P-Smad3C in TGF-Β-Activated Hepatic Stellate Cell Line LX-2
    Narges Mohammadtaghvaei et al, 2021, Hepat Mon CrossRef
72. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis
    Chao Yan et al, 2015, Parasites Vectors CrossRef
73. Lepidium sativum Secondary Metabolites (Essential Oils): In Vitro and In Silico Studies on Human Hepatocellular Carcinoma Cell Lines
    Shaimaa Nazir et al, 2021, Plants CrossRef
74. The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
    Noe Rico Montanari et al, 2021, Cancers CrossRef
75. Effect of Fibroblast Growth Factor 21 on the Expression of TLR4 and BAMBI Genes in Cholesterol-Treated Human Hepatic Stellate Cells
    Elham Shakerian et al, 2021, Jentashapir J Cell Mol Biol CrossRef
76. Diabetes complications and extracellular vesicle therapy
    Setareh Soltani et al, 2021, Rev Endocr Metab Disord CrossRef
77. Matching mouse models to specific human liver disease states by comparative functional genomics of mouse and human datasets
    Kaja Blagotinšek Cokan et al, 2021, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
78. Effect of Quercetin on the fructose-activated human hepatic stellate cells, LX-2, an in-vitro study
    Elham Shakerian et al, 2022, Mol Biol Rep CrossRef
79. Astragaloside IV suppresses migration and invasion of TGF-β1-induced human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways
    Lili Li et al, 2022, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
80. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
    Leonardo Stella et al, 2022, WJG CrossRef
81. Modeling of DNA Damage Repair and Cell Response in Relation to p53 System Exposed to Ionizing Radiation
    Ankang Hu et al, 2022, IJMS CrossRef
82. Coprinus comatus polysaccharides ameliorated carbon tetrachloride-induced liver fibrosis through modulating inflammation and apoptosis
    Huajie Zhao et al, 2022, Food Funct. CrossRef
83. A joint transcriptional regulatory network and protein activity inference analysis identifies clinically associated master regulators for biliary atresia
    Panpan Sun et al, 2022, Front. Pediatr. CrossRef
84. A High-Salt Diet Exacerbates Liver Fibrosis through Enterococcus -Dependent Macrophage Activation
    Xujun Zhang et al, 2023, Microbiol Spectr CrossRef
85. The anti-hepatic fibrosis effects of chlorogenic acid extracted from Artemisia Capillaris Herba on CCl4-induced mice via regulating TGF-β1/smad3 pathway
    Liping Huang et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef
86. The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects
    Zhanghao Li et al, 2023, Front. Endocrinol. CrossRef
87. Dynamic regulation of EXO1 promotes the progression from liver fibrosis to HCC through TGF-β1/Smad signaling feedback loop
    Mengting Li et al, 2024 CrossRef
88. Curcumin Modulates NOX Gene Expression and ROS Production via P-Smad3C in TGF-β-Activated Hepatic Stellate Cells
    Shahla Asadizadeh et al, 2024, IBJ CrossRef
89. The effect of saraglitazar on TGF-β-induced smad3 phosphorylation and expression of genes related to liver fibrosis in LX2 cell line
    Negar Dinarvand et al, 2024, Mol Biol Rep CrossRef
90. Role of microRNA-363 during tumor progression and invasion
    Arya Nasimi Shad et al, 2024, J Physiol Biochem CrossRef
91. A comprehensive review of miR-21 in liver disease: Big impact of little things
    Xinyan Xue et al, 2024, International Immunopharmacology CrossRef
92. Association between malignancies and Marfan syndrome: a population-based, nested case–control study in Taiwan
    Chin-Wang Hsu et al, 2017, BMJ Open CrossRef
93. Combination of Pirfenidone and Andrographolide Ameliorates Hepatic Stellate Cell Activation and Liver Fibrosis by Mediating TGF‐β/Smad Signaling Pathway
    Guang Xu et al, 2024, Analytical Cellular Pathology CrossRef
94. Potential Health Risks of Exposure to Graphene and Its Derivatives: A Review
    Huanyu Jin et al, 2025, Processes CrossRef
95. 1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation
    Yihan Zhao et al, 2025, Drug Res (Stuttg) CrossRef